Skip to Main Content

NISH (NITAG Support Hub) 13: Typhoid Conjugate Vaccine (TCV) : Domain 4: Availability of Vaccine

This Library Guide is a collection of useful documents & evidence on the safety, efficacy, effectiveness and impact of the Typhoid Conjugate Vaccine (TCV) to support NITAG members and other policy makers throughout Africa with making evidence-based recom

TCV and availability of vaccine

Fousseni, S., Ngangue, P., Barro, A., Ramde, S. W., Bihina, L. T., Ngoufack, M. N., ... & Salfo, O. (2025). Navigating the Road to Immunization Equity: Systematic Review of Challenges in Introducing New Vaccines into Sub-Saharan Africa’s Health Systems. Vaccines13(3), 269.  https://doi.org/10.3390/vaccines13030269

Mogasale, V. V., Sinha, A., John, J., Farooqui, H. H., Ray, A., Chantler, T., ... & Abbas, K. (2024). Typhoid conjugate vaccine implementation in India: A review of supportive evidence. Vaccine: X, 100568. https://doi.org/10.1016/j.jvacx.2024.100568

Mogasale, V., Ramani, E., Park, I. Y., & Lee, J. S. (2017). A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low-and middle-income countries to support vaccine introduction policy and decisions. Human Vaccines & Immunotherapeutics13(9), 2017-2024. https://doi.org/10.1080/21645515.2017.1333681

Steele, A. D., Carey, M. E., Kumar, S., MacLennan, C. A., Ma, L. F., Diaz, Z., & Zaidi, A. K. (2020). Typhoid conjugate vaccines and enteric fever control: where to next?. Clinical Infectious Diseases71(Supplement_2), S185-S190. https://doi.org/10.1093/cid/ciaa343

Debellut, F., Hendrix, N., Pitzer, V. E., Neuzil, K. M., Constenla, D., Bar-Zeev, N., ... & Pecenka, C. (2019). Forecasting demand for the typhoid conjugate vaccine in low-and middle-income countries. Clinical Infectious Diseases68(Supplement_2), S154-S160. ttps://doi.org/10.1093/cid/ciy1076

Sahastrabuddhe, S., & Saluja, T. (2019). Overview of the typhoid conjugate vaccine pipeline: current status and future plans. Clinical Infectious Diseases68(Supplement_1), S22-S26. https://doi.org/10.1093/cid/ciy884

Shakya, M., & Pollard, A. J. (2024). Typhoid conjugate vaccines: a step towards typhoid control. The Lancet Global Health12(4), e535-e536.https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900055-X

Birkhold, M., Mwisongo, A., Pollard, A. J., & Neuzil, K. M. (2021). Typhoid conjugate vaccines: advancing the research and public health agendas. The Journal of Infectious Diseases224(Supplement_7), S781-S787.https://doi.org/10.1093/infdis/jiab449

Nampota-Nkomba, N., Carey, M. E., Jamka, L. P., Fecteau, N., & Neuzil, K. M. (2023, May). Using typhoid conjugate vaccines to prevent disease, promote health equity, and counter drug-resistant typhoid fever. In Open Forum Infectious Diseases (Vol. 10, No. Supplement_1, pp. S6-S12). US: Oxford University Press. ttps://doi.org/10.1093/ofid/ofad022

Shakya, M., Neuzil, K. M., & Pollard, A. J. (2021). Prospects of future typhoid and paratyphoid vaccines in endemic countries. The Journal of infectious diseases224(Supplement_7), S770-S774.https://doi.org/10.1093/infdis/jiab393

Gloeck, N. R., Leong, T. D., Mthethwa, M., Iwu-Jaja, C. J., Katoto, P. D., Wiysonge, C. S., & Kredo, T. (2025). Typhoid conjugate vaccines for preventing typhoid fever (enteric fever). The Cochrane Database of Systematic Reviews2025(5), CD015746. doi: 10.1002/14651858.CD015746.pub2

Mogasale, V. V., Sinha, A., John, J., Farooqui, H. H., Ray, A., Chantler, T., ... & Abbas, K. (2024). Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ public health2(2).https://bmjpublichealth.bmj.com/content/bmjph/2/2/e001089.full.pdf